Latest treatment of multiple sclerosis Stories
MISSISSAUGA, ON, May 27, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in Ontario through the Ontario Public Drugs
- Consistent effects seen across key MRI measures of disease activity; Effects were sustained beyond two-year pivotal MS studies - - Approximately 80 percent of patients treated
Crowdfunding Gets FDA-Approved Stem Cell Trial Off To Fast Start New York, NY (PRWEB) April 15, 2014 The Tisch MS Research Center of New York (Tisch
DUBLIN, April 11, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/btp9ds/global_multiple) has announced the addition of the "Global
Patients Rapidly Shifting to New Oral Therapies PHILADELPHIA, March 18, 2014 /PRNewswire/ -- Health Union, LLC announced today on its website
Crowdfunding Site Targeted to Raise $300K for FDA-Approved Adult Stem Cell Trial New York, NY (PRWEB) March 17, 2014
ROCKVILLE, Md., March 10, 2014 /PRNewswire/ -- Synthetic Biologics, Inc.
DailyGossip.org reveals that multiple sclerosis is a complex condition that causes numerous symptoms.
MISSISSAUGA, ON, Feb.
Copayment Assistance Now Available to Medicare Patients Living with Multiple Sclerosis GAITHERSBURG, Md., Jan.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.